CTCX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CTCX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Carmell's inventories, raw materials & components for the quarter that ended in Sep. 2024 was $0.08 Mil.
Carmell's quarterly raw materials stayed the same from Mar. 2024 ($0.00 Mil) to Jun. 2024 ($0.00 Mil) but then increased from Jun. 2024 ($0.00 Mil) to Sep. 2024 ($0.08 Mil).
The historical data trend for Carmell's Inventories, Raw Materials & Components can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carmell Annual Data | |||||||
Trend | Dec21 | Dec22 | Dec23 | ||||
Inventories, Raw Materials & Components | - | - | - |
Carmell Quarterly Data | |||||||||||
Dec21 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Inventories, Raw Materials & Components | Get a 7-Day Free Trial | - | - | - | - | 0.08 |
Materials and components scheduled for use in making a product.
Richard A Upton | director | 12 MIDDLE STREET, AMHERST NH 03031 |
Kathryn Gregory | director | 305 THAYER POND ROAD, WILTON CT 06897 |
Patrick A Sturgeon | officer: CFO and Secretary | 600 LEXINGTON AVENUE 33 FLOOR, NEW YORK NY 10022 |
David W Anderson | director | 519 LYNMERE ROAD, BRYN MAWR PA 19010 |
Rajiv Shukla | director, 10 percent owner, officer: Chief Executive Officer | EMERALD VIEW SUITE 400, 2054 VISTA PARKWAY, WEST PALM BEACH FL 33411 |
Randolph W Hubbell | director, officer: President and CEO | C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203 |
William R Newlin | director | C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203 |
Steven Bariahtaris | director | C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203 |
Jaime Garza | director | C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203 |
Janet Vargo | officer: VP Clinical Services | C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203 |
Donna Godward | officer: Chief Quality Officer | C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203 |
James C Hart | officer: Chief Medical Officer | C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203 |
William Woodward | director | ANTHEM VENTURE PARTNERS, 225 ARIZONA AVENUE, SUITE 200, SANTA MONICA CA 90401 |
Darlene T Deremer | director | 200 CENTRAL AVENUE, SUITE 1850, ST. PETERSBURG FL 33701 |
Ahac Sponsor Iii Llc | 10 percent owner | 1177 AVENUE OF THE AMERICAS, 5TH FLOOR, NEW YORK NY 10036 |
From GuruFocus
By Business Wire • 07-27-2023
By PRNewswire • 09-12-2023
By Business Wire • 08-09-2023
By Marketwired • 07-29-2024
By Marketwired • 09-05-2023
By Marketwired • 09-05-2024
By GuruFocus News • 11-15-2024
By Marketwired • 04-11-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.